Clinical Scorecard: Pediatric abscess incidence may be higher postpandemic
At a Glance
| Category | Detail |
|---|---|
| Condition | Pediatric head and neck abscesses |
| Key Mechanisms | Increased incidence observed postpandemic without significant changes in demographics or treatment characteristics. |
| Target Population | Patients aged 18 years or younger with head and neck abscesses |
| Care Setting | Pediatric emergency departments |
Key Highlights
- Postpandemic incidence of head and neck abscesses was 3.28-fold higher than prepandemic.
- Incidence increased across various abscess types including cervical lymphadenitis and peritonsillar abscess.
- No new dominant pathogens identified; common organisms included Streptococcus species and Staphylococcus aureus.
- Clinical management remained largely similar across all periods studied.
- Inpatient mortality was 0% across all study periods.
Guideline-Based Recommendations
Diagnosis
- Clinically or radiographically confirm head and neck abscesses.
Management
- Prompt recognition and management of pediatric infections.
Monitoring & Follow-up
- Ongoing surveillance of pediatric head and neck abscess incidence.
Risks
- Potential for increased incidence in postpandemic settings.
Patient & Prescribing Data
194 patients aged 18 years or younger with confirmed head and neck abscesses.
No significant differences in time to antibiotic therapy or surgical intervention across periods.
Clinical Best Practices
- Maintain awareness of increased incidence of pediatric head and neck abscesses postpandemic.
- Consider similar management protocols across different periods.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
